Geneva – September 19, 2026 -- MindMaze Therapeutics (SIX: MMTX) will launch MindMotion Lite by the end of 2026, a tablet-based neurorehabilitation device designed to cut home deployment costs and expand access to intensive stroke and neurological therapy outside clinical settings.